by Admin | Mar 23, 2026 | Safety Signals
MHRA said Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure after a potential manufacturing error may have led to Amlodipine 5 mg Tablets being packed inside a carton labeled as Ramipril 5 mg Capsules. The agency said...
by Admin | Mar 22, 2026 | Safety Signals
MHRA says non-arteritic anterior ischemic optic neuropathy (NAION) has been very rarely reported with semaglutide and has updated product information for Wegovy, Ozempic, and Rybelsus accordingly. The agency advises urgent ophthalmology referral for patients who...
by Admin | Mar 18, 2026 | Safety Signals
MHRA says non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden vision deterioration, has been very rarely reported in association with semaglutide used for type 2 diabetes, weight management, and cardiovascular risk reduction....
by Admin | Mar 18, 2026 | Safety Signals
EMA’s Pharmacovigilance Risk Assessment Committee said it completed its review of a safety signal involving aseptic meningitis with Ixchiq, the live attenuated chikungunya vaccine, and recommended updating the vaccine’s product information to reflect the most recent...
by Admin | Mar 14, 2026 | Safety Signals
The UK’s Medicines and Healthcare products Regulatory Agency has warned that some patients may have been dispensed fake Mounjaro (tirzepatide) KwikPen 15mg pre-filled pens from The Private Pharmacy Clinic in Birmingham. MHRA said all affected fake pens identified so...
by Admin | Mar 14, 2026 | Safety Signals
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed its review of a safety signal involving aseptic meningitis with Ixchiq, the live attenuated chikungunya vaccine. EMA said PRAC has recommended an update to the product information to reflect the...
